215 related articles for article (PubMed ID: 22426202)
1. Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation.
Kleijn J; Wiskerke J; Cremers TI; Schoffelmeer AN; Westerink BH; Pattij T
Neurochem Int; 2012 Jun; 60(8):791-8. PubMed ID: 22426202
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
Heidbreder C; Feldon J
Synapse; 1998 Aug; 29(4):310-22. PubMed ID: 9661249
[TBL] [Abstract][Full Text] [Related]
3. Serotonin1B receptor ligands in the nucleus accumbens shell do not affect the discriminative stimulus effects of amphetamine in rats.
Filip M; Nowak E; Baran L; Przegaliński E
Pol J Pharmacol; 2001; 53(5):449-57. PubMed ID: 11990062
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
Giorgi O; Piras G; Lecca D; Corda MG
Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
[TBL] [Abstract][Full Text] [Related]
5. Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex.
Tanahashi S; Ueda Y; Nakajima A; Yamamura S; Nagase H; Okada M
Neuropharmacology; 2012 Apr; 62(5-6):2057-67. PubMed ID: 22266218
[TBL] [Abstract][Full Text] [Related]
6. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Quarta D; Valerio E; Hutcheson DM; Hedou G; Heidbreder C
Neurochem Int; 2010 Jan; 56(1):11-5. PubMed ID: 19737591
[TBL] [Abstract][Full Text] [Related]
7. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release.
Peleg-Raibstein D; Feldon J
Neuropharmacology; 2006 Oct; 51(5):947-57. PubMed ID: 16876207
[TBL] [Abstract][Full Text] [Related]
8. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
Auclair A; Blanc G; Glowinski J; Tassin JP
J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
[TBL] [Abstract][Full Text] [Related]
9. AMPA receptor mediates mGlu 2/3 receptor antagonist-induced dopamine release in the rat nucleus accumbens shell.
Karasawa J; Kotani M; Kambe D; Chaki S
Neurochem Int; 2010 Nov; 57(5):615-9. PubMed ID: 20674641
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.
De Luca MA; Bimpisidis Z; Melis M; Marti M; Caboni P; Valentini V; Margiani G; Pintori N; Polis I; Marsicano G; Parsons LH; Di Chiara G
Neuropharmacology; 2015 Dec; 99():705-14. PubMed ID: 26327678
[TBL] [Abstract][Full Text] [Related]
11. Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core.
McKittrick CR; Abercrombie ED
J Neurochem; 2007 Mar; 100(5):1247-56. PubMed ID: 17241132
[TBL] [Abstract][Full Text] [Related]
12. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
13. Differences in dopamine responsiveness to drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer 344 rats.
Cadoni C; Di Chiara G
J Neurochem; 2007 Oct; 103(2):487-99. PubMed ID: 17666048
[TBL] [Abstract][Full Text] [Related]
14. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
15. Neonatal ventral hippocampal lesions potentiate amphetamine-induced increments in dopamine efflux in the core, but not the shell, of the nucleus accumbens.
Corda MG; Piras G; Giorgi O
Biol Psychiatry; 2006 Dec; 60(11):1188-95. PubMed ID: 16934777
[TBL] [Abstract][Full Text] [Related]
16. In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens.
Ventura R; Alcaro A; Mandolesi L; Puglisi-Allegra S
J Neurochem; 2004 Apr; 89(2):494-502. PubMed ID: 15056292
[TBL] [Abstract][Full Text] [Related]
17. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
Pierce RC; Kalivas PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
[TBL] [Abstract][Full Text] [Related]
19. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex.
Lu W; Chen H; Xue CJ; Wolf ME
Synapse; 1997 Jul; 26(3):269-80. PubMed ID: 9183816
[TBL] [Abstract][Full Text] [Related]
20. Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission.
Pan WH; Sung JC; Fuh SM
J Pharmacol Exp Ther; 1996 Aug; 278(2):725-31. PubMed ID: 8768724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
